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journal homepage: www.e lsev ier .com/ locate /yse izWe were very honoured and excited to be approached to edit
this special edition of Seizure, which marks the 60th anniversary of
the founding of the UK patient organisation, Epilepsy Action (EA,
formerly The British Epilepsy Association). We have both been
involved with the work of EA over what is now a considerable
period of time – as research funding recipients, research
collaborators, members of the Council of Management and
Research Committee, members of the Research Advisory Group,
supporters and –we like to think – as friends. What better way, we
agreed, to celebrate EA’s history and achievements, than to edit
such a special edition – especially given that Seizure was founded
by EA and remains its ofﬁcial academic journal. So, wewant to start
by thanking Markus Reuber and Simon Wigglesworth for
proposing us as editors. We are very glad we said yes to the
request – working with all our contributors and reading/editing
their excellent and thought-provoking contributions has been one
of the most rewarding pieces of work we have ever done and we
are very proud of the end product. We hope readers will enjoy it as
much as we have.
The aim of this Special Edition was to highlight changes in the
way epilepsy has been thought about and dealt with over the 60
years of EA’s existence and to speculate a little on what the next 60
years holds for the clinical and social management of epilepsy. We
also wanted to highlight what has changed and what still needs to
change for people with epilepsy, not just in the UK but worldwide.
So – this is not a systematic ‘account’ of epilepsy, wherein we cover
all the epidemiological, neurobiological, clinical, psychiatric/
psychological and social bases – rather we wanted the content
to tune with EA’s stated aims to:
 Raise and maintain awareness about epilepsy.
 Educate people about the facts about epilepsy and improve their
understanding of the condition.
 Bring about permanent change for the social andmedical beneﬁt
of people with epilepsy.
 Provide advice and information about epilepsy.
 Promote all types of research into epilepsy and undertake social
and medical research into epilepsy.
 Ensure that epilepsy is fully understood and the needs of people
with epilepsy are supported.
Epilepsy Action has always been about people with epilepsy; so
from the beginning, we wanted this special edition to contain
articles from people with epilepsy themselves, matched by topic
with articles from academics working in the ﬁeld. We think this
matching has worked well, offering a unique take on the topics we
cover and turning the ‘academic’ into ‘lived experience’, described1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.10.013both verbally and through themedium of art. We hope our readers
will agree.
The history of epilepsy from the ancient Greeks through to
the beginnings of modern neurology at the end of the 19th
century is magniﬁcently described and analysed in the now
classic text by Temkin,1 The Falling Sickness. In his preface to
the ﬁrst edition, Temkin comments that a history of epilepsy
seems, ‘a doubtful enterprise’ given that ‘there is no unanimity
about the range of the concept of epilepsy and the fact that the
nature of the disease is as yet obscure.’ However, he also
comments that through studying ‘what was meant by epilep-
sy. . .how it was explained and how treated’ historically, we can
better understand the setting of present problems. We
wholeheartedly agree and think the articles included in the
special edition, by reﬂecting on past, present and future provide
much food for thought, both highlighting progress and remind-
ing us of challenges still to be met. In the epilogue to his work,
Temkin also notes that research on epilepsy is so intimately
interwoven with that of neurophysiology, electrophysiology,
biochemistry, pharmacology and psychology that any history of
epilepsy cannot be pursued separately from these, even if the
relationships remain uncertain. So much has happened in all
these different ﬁelds of scientiﬁc endeavour since Temkin’s
study was published in the mid-1940s, just shortly before
Epilepsy Action came into being – so tracing the history of at
least some of these different elements in the study of the
condition we call epilepsy across the 60-year period of its
existence, and speculating on what the next 60 years might hold,
seemed an appropriate and interesting focus for this special
edition. The articles here by John Jeffreys on electrophysiology,
Martin Brodie on drug therapy, Sarah Wilson and Jerome Engel
on neuropsychology and patho-anatomy in the context of
epilepsy surgery, Helen Cross on the ketogenic diet and Mark
Rees on genetics of epilepsy all address the complex interweav-
ing of disciplines highlighted by Temkin and our demand for a
historical reﬂection admirably. Just as powerful, however, in
conveying the impact of scientiﬁc developments on our
understanding of the nature of epilepsy are the accompanying
accounts from people with epilepsy themselves – Gus Cummins
and Josh Fox, both artists, on the experience of having seizures,
Alan Inglis on what is involved on a daily basis in managing
antiepileptic medications, Tristan Woolf on undergoing surgery,
Emma Williams on managing her son’s ketogenic diet, and
Caroline’s family, told through interviews with Carrie Ham-
mond, on going through the process of genetic testing.
What is critical from Temkin’s historical account, in relation
to Epilepsy Action’s activities over the last 60 years and to itsvier Ltd. All rights reserved.
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representing a centuries-long struggle between magical and
scientiﬁc conceptions of disease, a struggle which meant that
over time and place seizures, the manifestations of epilepsy,
have been variously viewed as the outcome of demonic
possession, the product of disturbance of bodily humours, the
result of toxins in the body and, latterly, the normal response of
the brain to an abnormal situation. The struggle for scientiﬁc control
of epilepsy began to be won during the period of the European
Enlightenment, at which time it came to be seen as the result of
rationally explicable and empirically measurable forces operating
within the laws of nature.2 Successive waves of scientiﬁc and
technological development from then forward have meant that
what has been referred to as the clinical ‘gaze’3 on epilepsy has
altered, but never lost its grip – thus, as a clinical condition epilepsy
now sits ﬁrmly within the discipline of neurology and present-day
technologies permit ever-more detailed examinations of its
structural and functional causes. Yet, it is salutary to recall
Pasternak’s2 comment that, ‘increasing rationalisation did not
ameliorate social prejudice against epilepsy, it merely caused one
form of prejudice to be substituted for another.’ As the articles by
Elaine Howell and Hanneke de Boer amply highlight, social world
concepts of epilepsy have tended to lag behind clinical world
concepts and epilepsy remains even in the present day, ‘not just a
clinical conditionbut a social label’4; andonewhich formanypeople
worldwide still carries considerable force.5 Furthermore, though the
shift from institutionalisation of people with epilepsy to ‘care in the
community’ is generally to be applauded, the situation is, as is
powerfully argued by Bert Aldenkamp and we are reminded by the
accounts fromWendy andMalcolmDavis, muchmore complex and
nuanced than that. And so, it remains aworld inwhich the activities
of organisations such as EA, so amply documented by Philip Lee and
Jayne Cage, are still much needed.So what needs to change in the next 60 years? At what aspects
of epilepsy should organisations like Epilepsy Action target their
Campaigns? Madelin Bexon and Steven Schachter both put
forward agenda for action which offer enormous challenges to
science, medicine and health and social care systems. Our
readers will almost certainly have their own additions to these
agenda.
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